<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Health and Prostate &#187; Prostate Gland</title>
	<atom:link href="http://healthandprostate.com/index.php/tag/prostate-gland/feed" rel="self" type="application/rss+xml" />
	<link>http://healthandprostate.com</link>
	<description>Benign Prostatic Hyperplasia - Prostate Cancer - Prostatitis</description>
	<lastBuildDate>Thu, 02 Sep 2010 13:59:28 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Comparison of the gross anatomy of the human and rat prostate</title>
		<link>http://healthandprostate.com/index.php/images-diagrams-tables/comparison-of-the-gross-anatomy-of-the-human-and-rat-prostate</link>
		<comments>http://healthandprostate.com/index.php/images-diagrams-tables/comparison-of-the-gross-anatomy-of-the-human-and-rat-prostate#comments</comments>
		<pubDate>Thu, 31 Dec 2009 06:31:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Images Diagrams Tables]]></category>
		<category><![CDATA[Prostate Gland]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=222</guid>
		<description><![CDATA[
PZ = peripheral zone; CZ = central zone; TZ = transition zone; fm = anterior fibromuscular stroma; UD = distal urethra; UP = proximal urethral segment; E = ejaculatory ducts; bn = bladder neck; s = preprostatic and distal striated urethral sphincters; C = coronal plane; OC = oblique coronal plane; BL = bladder; SV [...]]]></description>
			<content:encoded><![CDATA[<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fimages-diagrams-tables%2Fcomparison-of-the-gross-anatomy-of-the-human-and-rat-prostate&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
<div id="attachment_223" class="wp-caption aligncenter" style="width: 560px"><img class="size-full wp-image-223" title="Comparison of the gross anatomy of the human (left) and rat (right) prostate" src="http://healthandprostate.com/wp-content/uploads/2009/12/human-and-rat-prostate.jpg" alt="Comparison of the gross anatomy of the human (left) and rat (right) prostate" width="550" height="326" /><p class="wp-caption-text">Comparison of the gross anatomy of the human (left) and rat (right) prostate</p></div>
<p>PZ = peripheral zone; CZ = central zone; TZ = transition zone; fm = anterior fibromuscular stroma; UD = distal urethra; UP = proximal urethral segment; E = ejaculatory ducts; bn = bladder neck; s = preprostatic and distal striated urethral sphincters; C = coronal plane; OC = oblique coronal plane; BL = bladder; SV = seminal vesicles; CG = coagulating gland; V = ventral lobe of the prostate; L = lateral lobe of the prostate; D = distal lobe of the prostate; Bur G = bulbourethral gland; UR = urethra; PU = pubis; vas deferens; CE = cauda epididymis.</p>
<p><em>Reproduced from Price D. Comparative aspects of development and structure in the prostate. In: Vollmer EP, editor. Biology of the prostate and related tissues. Vol. XII. Bethesda (MD): Dept. of Health, Education, and Welfare (US); 1963.; and Jesik CJ, Holland JM, Lee C. An anatomic and his-tologic study of the rat prostate. Prostate 1982; 3.</em>
<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fimages-diagrams-tables%2Fcomparison-of-the-gross-anatomy-of-the-human-and-rat-prostate&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/index.php/images-diagrams-tables/comparison-of-the-gross-anatomy-of-the-human-and-rat-prostate/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Aspartate transport and citrate production in prostate luminal epithelial cells</title>
		<link>http://healthandprostate.com/index.php/images-diagrams-tables/aspartate-transport-and-citrate-production-in-prostate-luminal-epithelial-cells</link>
		<comments>http://healthandprostate.com/index.php/images-diagrams-tables/aspartate-transport-and-citrate-production-in-prostate-luminal-epithelial-cells#comments</comments>
		<pubDate>Tue, 29 Dec 2009 06:43:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Images Diagrams Tables]]></category>
		<category><![CDATA[Prostate Gland]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=226</guid>
		<description><![CDATA[
The low affinity L-aspartate transporter Na+-K+ ATPase and a citrate transporter are represented at the apical membrane. The high affinity L-aspartate transporter and glucose transporters are represented in the basal membrane.
Reproduced from Lao L, Franklin R B, Costello L C. High-affinity L-aspartate transporter in prostate epithelial cells that is regulated by testosterone. Prostate 1993; 22.

]]></description>
			<content:encoded><![CDATA[<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fimages-diagrams-tables%2Faspartate-transport-and-citrate-production-in-prostate-luminal-epithelial-cells&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
<div id="attachment_227" class="wp-caption aligncenter" style="width: 560px"><img class="size-full wp-image-227" title="Aspartate transport and citrate production in prostate luminal epithelial cells" src="http://healthandprostate.com/wp-content/uploads/2009/12/prostate-luminal-epithelial-cells.jpg" alt="Aspartate transport and citrate production in prostate luminal epithelial cells" width="550" height="417" /><p class="wp-caption-text">Aspartate transport and citrate production in prostate luminal epithelial cells</p></div>
<p>The low affinity L-aspartate transporter Na<sup>+</sup>-K<sup>+</sup> ATPase and a citrate transporter are represented at the apical membrane. The high affinity L-aspartate transporter and glucose transporters are represented in the basal membrane.</p>
<p><em>Reproduced from Lao L, Franklin R B, Costello L C. High-affinity L-aspartate transporter in prostate epithelial cells that is regulated by testosterone. Prostate 1993; 22.</em>
<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fimages-diagrams-tables%2Faspartate-transport-and-citrate-production-in-prostate-luminal-epithelial-cells&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/index.php/images-diagrams-tables/aspartate-transport-and-citrate-production-in-prostate-luminal-epithelial-cells/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Effects of tissue localization of the androgen receptor on differentiation of the urogenital sinus</title>
		<link>http://healthandprostate.com/index.php/images-diagrams-tables/effects-of-tissue-localization-of-the-androgen-receptor-on-differentiation-of-the-urogenital-sinus</link>
		<comments>http://healthandprostate.com/index.php/images-diagrams-tables/effects-of-tissue-localization-of-the-androgen-receptor-on-differentiation-of-the-urogenital-sinus#comments</comments>
		<pubDate>Fri, 18 Dec 2009 06:21:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Images Diagrams Tables]]></category>
		<category><![CDATA[Prostate Gland]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=217</guid>
		<description><![CDATA[
Epithelium and stroma from the urogenital sinuses of wild-type (androgen-receptor positive) or Tfm (androgen-receptor negative) mice were recombined and grafted under the renal capsule. Prostatic epithelium was obtained when wild-type or Tfm epithelium was recombined with wild-type stroma. Recombination of wild-type or Tfm epithelium with Tfm stroma resulted in development of a vaginal morphology.
Reproduced with [...]]]></description>
			<content:encoded><![CDATA[<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fimages-diagrams-tables%2Feffects-of-tissue-localization-of-the-androgen-receptor-on-differentiation-of-the-urogenital-sinus&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
<div id="attachment_218" class="wp-caption aligncenter" style="width: 410px"><img class="size-full wp-image-218" title="Effects of tissue localization of the androgen receptor on differentiation of the urogenital sinus (UGS)" src="http://healthandprostate.com/wp-content/uploads/2009/12/urogenital-sinus.jpg" alt="Effects of tissue localization of the androgen receptor on differentiation of the urogenital sinus (UGS)" width="400" height="562" /><p class="wp-caption-text">Effects of tissue localization of the androgen receptor on differentiation of the urogenital sinus (UGS)</p></div>
<p>Epithelium and stroma from the urogenital sinuses of wild-type (androgen-receptor positive) or Tfm (androgen-receptor negative) mice were recombined and grafted under the renal capsule. Prostatic epithelium was obtained when wild-type or Tfm epithelium was recombined with wild-type stroma. Recombination of wild-type or Tfm epithelium with Tfm stroma resulted in development of a vaginal morphology.</p>
<p><em>Reproduced with permission from Cunha G R, Chung W K, Shannon J M, Reese B G. Stromal-epithelial interactions in sex differentiation. Biol Reprod 1980; 22.</em>
<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fimages-diagrams-tables%2Feffects-of-tissue-localization-of-the-androgen-receptor-on-differentiation-of-the-urogenital-sinus&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/index.php/images-diagrams-tables/effects-of-tissue-localization-of-the-androgen-receptor-on-differentiation-of-the-urogenital-sinus/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medical Treatment of the Prostate Gland. Part 16. Summary</title>
		<link>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-16-summary</link>
		<comments>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-16-summary#comments</comments>
		<pubDate>Mon, 14 Dec 2009 05:28:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Old Publications]]></category>
		<category><![CDATA[Benign Prostatic Hyperplasia (BPH)]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Prostate Gland]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=201</guid>
		<description><![CDATA[
The Department of Urology of the New York Hospital
(Given January 31, 1941)
Attention  is called to the effect of disease of the prostate gland in the young as well  as the old.
Young  men are liable to acute and chronic inflammation of the prostate, sometimes  producing abscess, requiring surgery, but more often causing [...]]]></description>
			<content:encoded><![CDATA[<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-16-summary&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
<p>The Department of Urology of the New York Hospital<br />
(Given January 31, 1941)</p>
<p>Attention  is called to the effect of disease of the prostate gland in the young as well  as the old.</p>
<p>Young  men are liable to acute and chronic <a href="http://healthandprostate.com/index.php/pharmacotherapy/immunotherapies-for-prostate-cancer">inflammation</a> of the prostate, sometimes  producing abscess, requiring surgery, but more often causing low back pain,  urinary disturbances, and sexual disturbances. Non-surgical treatment is  indicated in the latter; this consists of massage, urethral dilatation,  urethrovesical irrigations, chemotherapy, hydrotherapy, diathermy, and other  forms of physiotherapy. Tuberculosis of the prostate occurs fairly frequently  in young men, and is usually part of a progressive urogenital tuberculosis.  Treatment, as a rule, is non-surgical. Sarcoma of the prostate, a rare disease  that is almost invariably fatal, affects young men and even children relatively  often.</p>
<p>Appropriate  diet and medication are indicated in all prostatic conditions.</p>
<p>Older  men are subject to prostatic calculosis, and all forms of obstructive  prostatism, both benign and malignant. Appropriate surgical methods must be  applied after careful investigation has revealed the exact conditions that prevail.</p>
<p>In less  than 5 per cent of cases of carcinoma of the prostate gland is the malignancy  discovered in time to effect a cure by total extirpation. This is because there  are no symptoms in early stages of the disease. It is therefore an important  duty of the general practitioner and the family doctor to do a rectal  examination on every male patient over 50 years of age, and to investigate  thoroughly every case in which the prostate is not perfectly normal.
<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-16-summary&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-16-summary/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medical Treatment of the Prostate Gland. Part 15</title>
		<link>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-15</link>
		<comments>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-15#comments</comments>
		<pubDate>Mon, 14 Dec 2009 05:27:27 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Old Publications]]></category>
		<category><![CDATA[Benign Prostatic Hyperplasia (BPH)]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Prostate Gland]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=199</guid>
		<description><![CDATA[
The Department of Urology of the New York Hospital
(Given January 31, 1941)
Benign Hypertrophy of the Prostate
In all  other cases, perineal prostatectomy is done. This includes enlargements  which encroach on the posterior urethra. Prostatectomy for the removal of a  malignant gland, or for long-standing chronic inflammation, is also  accomplished through the perineum. [...]]]></description>
			<content:encoded><![CDATA[<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-15&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
<p>The Department of Urology of the New York Hospital<br />
(Given January 31, 1941)</p>
<h3>Benign Hypertrophy of the Prostate</h3>
<p>In all  other cases, <em>perineal prostatectomy </em>is done. This includes enlargements  which encroach on the posterior urethra. Prostatectomy for the removal of a  malignant gland, or for long-standing chronic <a href="http://healthandprostate.com/index.php/pharmacotherapy/immunotherapies-for-prostate-cancer">inflammation</a>, is also  accomplished through the perineum. A recent modification of the usual perineal  prostatectomy, by the author, has reduced postoperative incontinence of urine  to a minimum. This consists in plicating the membranous urethra just external  to the apex of the prostate by the insertion of a mattress suture of ribbon  gut.</p>
<p>Recently,  patients suffering from enlargement of the prostate, who have passed the period  of sexual activity, have been operated upon by means of a <em>subtotal  prostatectomy, </em>which is accomplished as follows: The prostate gland is  exposed by the perineal route in the usual manner. The lateral surfaces of the  gland are exposed, which is usually easily accomplished as there are seldom any  adhesions from these aspects of the organ. The apex is then cut across and the  entire gland and capsule excised except for a small strip of the anterior  commissure. The seminal vesicles and ampullae of the vasa deferentia are cut across.  The neck of the bladder is brought in contact with the membranous urethra by  means of a mattress suture which not only approximates these structures and  plicates the urethra, but stops all bleeding as well, thus doing away with the  necessity of packing.</p>
<p>Our  results with this modified perineal operation are so good that we perform it by  choice unless the patient is still active sexually. In the latter case, it is  unwise to do this procedure as the seminal vesicles and ampullae of the vasa  deferentia are cut across, and ejaculation is impossible.</p>
<p><em>Preliminary preparation of the patient </em>is of the greatest importance irrespective of the type of operation  selected. This consists primarily of properly managed drainage, which is  accomplished either by (1) a suprapubic cystostomy, with suction drainage, or  (2) an indwelling urethral catheter.</p>
<p><em>Complications </em>in prostatectomy by any of  the three techniques mentioned are approximately the same. The mortality rate  is lower in trans-urethral prostatectomy than in the suprapubic and perineal  procedures because the large majority of these operations are done on much  younger men.
<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-15&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-15/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medical Treatment of the Prostate Gland. Part 14</title>
		<link>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-14</link>
		<comments>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-14#comments</comments>
		<pubDate>Sun, 13 Dec 2009 05:26:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Old Publications]]></category>
		<category><![CDATA[Benign Prostatic Hyperplasia (BPH)]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Prostate Gland]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=197</guid>
		<description><![CDATA[
The Department of Urology of the New York Hospital
(Given January 31, 1941)
Benign Hypertrophy of the Prostate
Treatment. Many patients with benign hypertrophy of the  prostate have no obstructive symptoms and do not require surgery. In benign  hypertrophy without residual urine, palliative treatment is usually  advisable; this consists of periodic prostatic massage, urethral dilatations, [...]]]></description>
			<content:encoded><![CDATA[<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-14&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
<p>The Department of Urology of the New York Hospital<br />
(Given January 31, 1941)</p>
<h3>Benign Hypertrophy of the Prostate</h3>
<p><em>Treatment. </em>Many patients with benign hypertrophy of the  prostate have no obstructive symptoms and do not require surgery. In benign  hypertrophy without residual urine, <em>palliative treatment </em>is usually  advisable; this consists of periodic prostatic massage, urethral dilatations,  urethrovesical irrigations, the application of heat to the prostate, and  hydrotherapy. Periodic check-up is essential.</p>
<p><em>Hormonal therapy </em>affords symptomatic relief in some early cases  of prostatism with slight or moderate urinary disturbances; but even its most  enthusiastic advocates do not claim that it benefits all types of cases, or  that it is to be considered a substitute for surgical relief in major prostatic  obstruction.</p>
<p><em>Roentgen therapy </em>of benign hypertrophy also is an accepted  procedure, but opinions vary as to the effect of such treatment. The more  conservative urologists and radiotherapists incline to the opinion that the  only effects of irradiation are a definite alleviation of the associated  congestion and edema, giving temporary relief in selected cases. It cannot,  however, be regarded as a substitute for prostatectomy or resection.</p>
<p><em>Surgical treatment </em>is usually required in cases with residual  urine. Every patient presents an individual problem, and the type of operation  selected should be the one best suited to the case in question. It has always  been our contention that every well-trained urological surgeon should be  psychologically and technically equipped to perform any operation in urology.  To that end, we train our young men in the proper technique of perineal,  suprapubic, and transurethral prostatectomy. Each of these has its place in  urological surgery. By limiting his surgery to one of these methods only, the  operator limits his usefulness to his patients.</p>
<p>Widespread interest has been manifested in the past  two decades, by both the medical profession and the laity, in transurethral  resection of the prostate. In 1913, Hugh Young developed a  method of transurethral surgery for certain types of enlargement of the  subcervical group of tubules. This operation, called the Young punch operation,  did more efficiently and less dangerously what the Italian Bottini operation  (performed through an external urethrotomy wound) was designed to do. Young&#8217;s  operation was modified and improved, in 1920, by the late John Caulk, of St.  Louis, who added a cauterizing element. In 1926, at The New York Academy of  Medicine, Maximilian Stern presented a resection instrument made for him by the  late Rheinold Wappler. This instrument was too small to be entirely effective,  but it was soon improved by Bumpus, Collings, McCarthy, Foley, Kirwin, and  others.</p>
<p>A tremendous wave of enthusiasm swept this country  and extended abroad, and for a time claims were made to the effect that open  surgery upon the prostate gland was doomed to oblivion. As the fanaticism  subsided, there also died down the extravagant claims that transurethral  surgery was an office procedure, and that any prostate of any size could be  removed without the preliminary preparation of the patient which had reduced  the mortality of the open operation from nearly 50 per cent to about 6 per  cent. It soon became evident that this surgical maneuver was not as simple as  it had at first seemed. One great harm done by its too ardent protagonists was  that their claims gave every doctor who could manipulate a cystoscope the idea  that he could perform the transurethral operation. Such, of course, was not the  case, and the mortality of these amateur surgeons was tremendous.</p>
<p>Transurethral resection has a permanent and highly  important place in surgery of the vesical neck, and with the passage of time  its scope and limitations are being better defined. It is true that the method  has a slightly geographic aspect; most of those who believe in transurethral  prostatectomy to the exclusion of the open operation, it has been noted, live  in the Midwest.</p>
<p>Before deciding which operation to perform in a  given case, one must determine the type of enlargement present. In general, it  is our practice to remove by means of <em>transurethral resection </em>all  enlargements of the middle lobe and of the subcervical group of tubules, all  fibrous bars, and certain obstructions due to malignancy of the prostate. We  prefer to use the Kirwin rotary resectoscope as a rule.</p>
<p>If the enlargement of the gland is mainly  intravesical, <em>suprapubic prostatectomy </em>is the method of choice. The  operation employed is the so-called Fuller-Freyer technique. In this procedure,  the capsule over the most prominently presenting part of the gland is incised,  and from this point the enucleation is accomplished. Care is taken not to split  the anterior commissure as by so doing one often tears into the plexus of  Santorini on the anterior surface of the prostate, greatly increasing the  bleeding.
<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-14&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-14/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medical Treatment of the Prostate Gland. Part 13</title>
		<link>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-13</link>
		<comments>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-13#comments</comments>
		<pubDate>Sun, 13 Dec 2009 05:25:53 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Old Publications]]></category>
		<category><![CDATA[Benign Prostatic Hyperplasia (BPH)]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Prostate Gland]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=195</guid>
		<description><![CDATA[
The Department of Urology of the New York Hospital
(Given January 31, 1941)
Benign Hypertrophy of the Prostate
Benign hypertrophy of the prostate gland occurs in  from one-third to one-fifth of all men over 50 years of age.
Etiology. Many theories have been  advanced as to why the prostate tends to hypertrophy with age. The chief are: [...]]]></description>
			<content:encoded><![CDATA[<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-13&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
<p>The Department of Urology of the New York Hospital<br />
(Given January 31, 1941)</p>
<h3>Benign Hypertrophy of the Prostate</h3>
<p>Benign hypertrophy of the prostate gland occurs in  from one-third to one-fifth of all men over 50 years of age.</p>
<p><em>Etiology. </em>Many theories have been  advanced as to why the prostate tends to hypertrophy with age. The chief are:  (i) that the hypertrophy is due to true tumor formation, which takes its  origin, according to some, from the periurethral accessory glands, or, according  to others, from any part of the prostate gland proper; (2) that it is a  fibroepithelial growth akin to myoma of the uterus; (3) that the condition is a  cystic glandular hyperplasia having its basis in infection of long standing;  (4) that the hyperplasia is endocrinopathic, and due to an improper balance  between the male and female hormones.</p>
<p><em>Pathology. </em>Benign hypertrophy of the  prostate most frequently occurs in the middle and lateral lobes — the anterior lobe being  affected rarely, and the posterior lobe practically never. My studies show that  the portion which enlarges most frequently is really a contiguous structure — the  subcervical group of tubules. These may enlarge without hypertrophy of the  prostate; but when the prostate proper is enlarged, the subcervical group will  also be hypertrophied. If a portion of the gland protrudes into the bladder, it  will usually be found to be the subcervical group of tubules.</p>
<p>Microscopically,  four types of benign enlargement may be distinguished: glandular, cystic, fibroglandular,  and fibrous. The much-discussed question as to whether adenomas or fibromyomas  predominate in prostatic hypertrophy is of little practical importance as it is  established that a pure formation of either type never occurs.</p>
<p>In  prostatic hypertrophy there is a definite line of cleavage between the capsule  and the prostatic tissue, making separation of the adenomatous prostate from  the capsule an easy matter.</p>
<p><em>Symptoms. </em>Enlargement of the prostate  is usually an insidious disease, which develops slowly and is marked by  gradually increasing frequency and nocturia. The patient notices that the  character of the stream changes: it is often slow in starting, and lacks force.  Men take this as evidence of advancing age and often pay little attention to it.  The condition gradually gets worse, and is usually accompanied by urinary  infection. Often microscopic blood is present, and occasionally macroscopic  hematuria. In the rare case, complete obstruction of urination may occur  without any premonitory symptoms.</p>
<p>The  urine usually contains pus, blood, and albumin. If the disease is of long  standing, casts are found, and the phenolsulphonphthalein test will show  diminished renal function. The blood urea is increased, sometimes very greatly; but unless there is  fever, the blood count is usually within normal limits.</p>
<p><em>Diagnosis. </em>The patient should be given a careful general  and special examination, including rectal palpation, an estimation of the  amount of residual urine, determination of the renal function, and a  cystoscopic examination to ascertain the exact nature of the enlargement. The  size of the prostate as felt by rectum has nothing to do with its obstructiveness,  and cystoscopy, or cysto-urethrography, is essential to determine the extent of  the intravesical and intraurethral intrusion.
<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-13&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-13/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medical Treatment of the Prostate Gland. Part 12</title>
		<link>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-12</link>
		<comments>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-12#comments</comments>
		<pubDate>Sat, 12 Dec 2009 05:25:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Old Publications]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Prostate Gland]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=193</guid>
		<description><![CDATA[
The Department of Urology of the New York Hospital
(Given January 31, 1941)
Carcinoma of the Prostate  Gland
Carcinoma of the prostate, because of its frequency  and its essentially fatal nature, presents the urologist with his most baffling  problem. Young&#8217;s statistics (1935) reveal that a fifth of the male patients who  seek relief of [...]]]></description>
			<content:encoded><![CDATA[<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-12&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
<p>The Department of Urology of the New York Hospital<br />
(Given January 31, 1941)</p>
<h3>Carcinoma of the Prostate  Gland</h3>
<p>Carcinoma of the prostate, because of its frequency  and its essentially fatal nature, presents the urologist with his most baffling  problem. Young&#8217;s statistics (1935) reveal that a fifth of the male patients who  seek relief of obstruction of the vesical neck have carcinoma of the prostate.</p>
<p><em>Pathology. </em>A striking morphologic peculiarity of carcinoma  of the prostate gland, that has been emphasized by most authors, is the  diversity of its forms. In the same case, in different portions, the  carcino-matous proliferation may be found at one time as an adenocarcinoma and  again as a scirrhous, a medullary, or a squamous-cell carcinoma.</p>
<p>A large percentage of prostatic carcinomas are  associated with benign hypertrophy. In only 10 (13 per cent) of the 72 cases  studied by Wilson and McGrath was there no evidence of associated hypertrophy.</p>
<p><em>Chart I </em></p>
<p><strong>Incidence, By Age-Groups, of Carcinoma in Relation to  Benign Enlargement in 280 Cases </strong></p>
<table border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td width="66" valign="top">
<p>Age of group</td>
<td width="66" valign="top">Prostates examined</td>
<td width="85" valign="top">Per cent showing carcinoma</td>
<td width="84" valign="top">Per cent showing benign enlargement</td>
<td width="86" valign="top">Per cent of carcinomas which arose in a prostate    with benign enlargement</td>
<td width="76" valign="top">Per cent of benign enlargement which also showed    carcinoma</td>
</tr>
<tr>
<td width="66" valign="top">
<p align="center">31-40</p>
</td>
<td width="66" valign="top">
<p align="center">28</p>
</td>
<td width="85" valign="top">
<p align="center">0%</p>
</td>
<td width="84" valign="top">
<p align="center">4% ( 1)</p>
</td>
<td width="86" valign="top">
<p align="center">0%</p>
</td>
<td width="76" valign="top">
<p align="center">0%</p>
</td>
</tr>
<tr>
<td width="66" valign="top">
<p align="center">41-50</p>
</td>
<td width="66" valign="top">
<p align="center">23</p>
</td>
<td width="85" valign="top">
<p align="center">17% ( 4)</p>
</td>
<td width="84" valign="top">
<p align="center">30% ( 7)</p>
</td>
<td width="86" valign="top">
<p align="center">25%</p>
</td>
<td width="76" valign="top">
<p align="center">14%</p>
</td>
</tr>
<tr>
<td width="66" valign="top">
<p align="center">51-60</p>
</td>
<td width="66" valign="top">
<p align="center">65</p>
</td>
<td width="85" valign="top">
<p align="center">14% ( 9)</p>
</td>
<td width="84" valign="top">
<p align="center">37% (24)</p>
</td>
<td width="86" valign="top">
<p align="center">50%</p>
</td>
<td width="76" valign="top">
<p align="center">21%</p>
</td>
</tr>
<tr>
<td width="66" valign="top">
<p align="center">61-70</p>
</td>
<td width="66" valign="top">
<p align="center">77</p>
</td>
<td width="85" valign="top">
<p align="center">23% (18)</p>
</td>
<td width="84" valign="top">
<p align="center">67% (52)</p>
</td>
<td width="86" valign="top">
<p align="center">66%</p>
</td>
<td width="76" valign="top">
<p align="center">23%</p>
</td>
</tr>
<tr>
<td width="66" valign="top">
<p align="center">71-80</p>
</td>
<td width="66" valign="top">
<p align="center">63</p>
</td>
<td width="85" valign="top">
<p align="center">21% (13)</p>
</td>
<td width="84" valign="top">
<p align="center">68% (43)</p>
</td>
<td width="86" valign="top">
<p align="center">46%</p>
</td>
<td width="76" valign="top">
<p align="center">14%</p>
</td>
</tr>
<tr>
<td width="66" valign="top">
<p align="center">81-90</p>
</td>
<td width="66" valign="top">
<p align="center">24</p>
</td>
<td width="85" valign="top">
<p align="center">29% ( 7)</p>
</td>
<td width="84" valign="top">
<p align="center">75% (18)</p>
</td>
<td width="86" valign="top">
<p align="center">71%</p>
</td>
<td width="76" valign="top">
<p align="center">27%</p>
</td>
</tr>
</tbody>
</table>
<p>In his very complete study of 280 prostates from men  between the ages of 31 and 90 years, Robert A. Moore found the occurrence of  carcinoma and benign enlargement to be as shown in Chart I. It is evident,  therefore, that the possibility of carcinoma must be kept in mind in every case  of prostatic hypertrophy.</p>
<p>Numerous careful studies show that in over 75 per  cent of cases the carcinoma starts in the posterior lobe (the portion of the  gland which does not participate in benign adenomatous hypertrophy).</p>
<p>Prostatic carcinoma is, as a rule, insidious and  slow-growing, though highly malignant, and may remain confined to the prostate  and periprostatic region for long periods. Only 10 to 20 per cent, according to  Barringer, are radiosensitive.</p>
<p>In many cases, by the time the growth has become  sufficiently advanced to be clinically diagnosed, it has extended beyond the  posterior lobe into the lateral and median lobes and upward to the base of the  prostate. There it may penetrate the capsule and involve the seminal vesicles.  Through the prostate&#8217;s rich supply of lymphatics, the carcinoma may extend to  the pelvic nodes, or, by the perirectal plexus, to the abdominal nodes.  Dissemination through the blood stream may occur early, and distant metastases,  particularly in the bones, are often detected before the occurrence of local  symptoms. The small prostatic tumor often disseminates widely. The high  frequency of skeletal metastases, and the predilection for the pelvis and  lumbar vertebrae, have been noted by practically all observers.</p>
<p><em>Symptoms. </em>The symptoms are not characteristic.  Disturbances of urination are usually the first symptoms, but advanced  carcinoma may be present without urinary symptoms. Pain —  referred to the sacroiliac region, rectum, perineum, or suprapubic area — is  often an early symptom, and may be due to metastases to the bones. Terminal  hematuria, retention, loss of weight and strength, and constipation are  significant, but late, symptoms.</p>
<p><em>Diagnosis. </em>Carcinoma of the prostate has, unfortunately,  usually existed for a long period by the time it is recognized. The diagnosis  is based upon the findings of rectal palpation and microscopic examination of a  biopsy specimen removed by means of an instrument, such as the Lowsley biopsy  instrument. In well-advanced cases recognition is usually not difficult; but in  early cases, in the soft (medullary) type of carcinoma, and in carcinoma  superimposed upon a benign hypertrophy, diagnosis may be difficult. A single,  small nodule may easily escape notice, especially when masked by edematous  prostatic tissue or in the absence of symptoms. The entire gland may be  irregularly enlarged, of a board-like hardness, and fixed; but usually the  growth is in the form of a nodule or hardened area in the posterior lobe, where  it is readily palpable by rectum. Evidence of the fixed gland may be seen on  cystourethroscopic examination.</p>
<p><em>Prognosis and Treatment. </em>The prognosis in the past has been cheerless  in the extreme. Over 95 per cent of the cases are beyond cure when first seen.  The high early incidence of pelvic lymphadenopathy, capsular infiltration and  invasion of the contiguous structures, and skeletal metastases precludes the  successful surgical treatment of the disease in most cases.</p>
<p>In cases in which the carcinoma is confined to the  prostate and periprostatic region, total or subtotal perineal prostatectomy  yields a fair percentage of cures estimated upon a 3 to 5 years&#8217; basis, and  prolongations of life for considerably longer periods are not uncommon. If seen  too late for hope of radical removal, partial perineal prostatectomy, or  transurethral resection of the obstruction, with implantation of radon seeds,  is the method of choice.</p>
<p>Improvement in prognosis is dependent on an increase  in the number of early diagnoses, with radical removal.
<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-12&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-12/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medical Treatment of the Prostate Gland. Part 11</title>
		<link>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-11</link>
		<comments>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-11#comments</comments>
		<pubDate>Sat, 12 Dec 2009 05:24:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Old Publications]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Prostate Gland]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=191</guid>
		<description><![CDATA[
The Department of Urology of the New York Hospital
(Given January 31, 1941)
Sarcoma of the Prostate
Sarcoma of the prostate is relatively rare, and may  occur at any age. A review of the literature by Lowsley and Kimball, in 1934,  disclosed only 132 reported cases, 35 of which occurred in patients under 22  years [...]]]></description>
			<content:encoded><![CDATA[<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-11&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
<p>The Department of Urology of the New York Hospital<br />
(Given January 31, 1941)</p>
<h3>Sarcoma of the Prostate</h3>
<p>Sarcoma of the prostate is relatively rare, and may  occur at any age. A review of the literature by Lowsley and Kimball, in 1934,  disclosed only 132 reported cases, 35 of which occurred in patients under 22  years of age. These tumors usually grow rapidly and attain large size, early  infiltrating the bladder, seminal vesicles, and rectum. Growth of the tumor  backward beneath the base of the bladder pushes the latter upward and forward,  causing obstruction of the ureteral orifices, urethral orifice, and urethra,  with resultant partial or complete retention. Growth of the tumor toward the  perineum causes prolapse of the rectum, with obstruction to defecation and  urination.</p>
<p><em>Diagnosis. </em>Early diagnosis is essential. In early cases  rectal examination may be negative, but usually reveals a palpable nodule.  Occasionally the growth may be indurated and nodular, but usually it is of  uniform consistency and has an elastic &#8220;balloon-like&#8221; feel; hence the  condition may be erroneously diagnosed as abscess. The diagnosis can positively  be made by needle biopsy.</p>
<p><em>Prognosis and Treatment. </em>The prognosis is poor. The most favorable  results have been achieved through the use of radium and Roentgen rays. In  early cases, the skilled use of these agents may prove curative, and in late  cases they may give relief and prolong life. Operative intervention should be  limited to the relief of obstruction and the treatment of complications.
<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-11&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-11/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medical Treatment of the Prostate Gland. Part 10</title>
		<link>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-10</link>
		<comments>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-10#comments</comments>
		<pubDate>Fri, 11 Dec 2009 05:23:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Old Publications]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Prostate Gland]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=189</guid>
		<description><![CDATA[
The Department of Urology of the New York Hospital
(Given January 31, 1941)
Prostatic Calculus
Incidence and Etiology. Prostatic calculi are relatively common. In an  autopsical study of 250 prostates from subjects of all ages, I found one or  more stones in approximately one-fifth of the glands.
Prostatic calculosis may occur at any period of  life, [...]]]></description>
			<content:encoded><![CDATA[<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-10&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
<p>The Department of Urology of the New York Hospital<br />
(Given January 31, 1941)</p>
<h3>Prostatic Calculus</h3>
<p><em>Incidence and Etiology. </em>Prostatic calculi are relatively common. In an  autopsical study of 250 prostates from subjects of all ages, I found one or  more stones in approximately one-fifth of the glands.</p>
<p>Prostatic calculosis may occur at any period of  life, but is rare before the age of 30 years. Of the twenty-three patients  reported on by Lowsley and Hawes, only one was under 40 years of age.</p>
<p>Distinction must be made between (1) endogenous, or  true prostatic calculi, namely, concretions formed within the prostatic  substance, and (2) exogenous, or false calculi, which are urinary stones that  have lodged in the prostatic urethra or have formed primarily from urinary  sediments in a communicating pouch. The nucleus of a true prostatic stone is  composed of organic material of an albuminoid nature: corpora amylacea, a blood  clot, epithelial detritus, a clump of bacteria, or necrotic tissue from an  abscess. The inorganic element forming the laminated layers about the nucleus  is composed of inorganic salts.</p>
<p>The exact etiology of true prostatic stones is  unknown. The most commonly held theory is that first advanced by Thompson in  1868, namely, that they have their origin in corpora amylacea, which, under  certain conditions, act as foreign bodies and set up an inflammatory reaction  in the mucous membrane of the acini enclosing them, as a result of which  calcium phosphates and carbonates are cast off; these impregnate the corpora  amylacea and convert them into calculi.</p>
<p><em>Pathology. </em>True prostatic calculi are usually multiple,  small, rounded (without facets), and scattered indiscriminately throughout the  parenchyma. Occasionally a cluster of stones will be found in one lobe while  the remaining lobes are free of calculi. Sometimes there will be a single large  stone, or one large stone in association with numerous smaller ones.</p>
<p>Microscopically, the portion of the gland containing  the calculi shows distended acini, the mucosal linings of  which are infiltrated by lymphocytes or by polymorphonuclear leukocytes.</p>
<p>Benign adenomatous hypertrophy and prostatic  calculosis not infrequently occur together (18 of 23 cases, Lowsley and Hawes).  The calculi are seldom, if ever, located within the adenoma, but are found  between it and the capsule, embedded in the remnants of the true prostate.  Frequently, however, calculi-containing prostates show no sign of hypertrophy.  They may be senile and fibrotic, with atrophy of the parenchyma and evidence of  <a href="http://healthandprostate.com/index.php/pharmacotherapy/immunotherapies-for-prostate-cancer">inflammation</a>.</p>
<p><em>Symptoms and Diagnosis. </em>The most important symptoms are disturbances  of urination, the actual passage of calculi either spontaneously or following  massage, and localized or referred pain —  in the perineum, suprapubic region, rectum, or down the penile shaft. In many  cases the symptoms are overshadowed by those of an associated hypertrophy or  prostatitis. In others, no symptoms are present, and the stones are discovered  accidentally.</p>
<p>It .is frequently possible to make a presumptive  diagnosis of prostatic calculi by the rectal palpation of a hard, circumscribed  area suggestive of stone or a nodule, or by the eliciting of crepitation.  Urethroscopic examination may reveal the presence of stones in the prostatic  ducts. Positive diagnosis is made by roentgenography. Cysto-urethrograms are of  value not only in revealing the calculi, but in determining the type and degree  of obstruction to urination, and associated pathology, if present.</p>
<p><em>Treatment. </em>Small calculi, that are discovered  accidentally and give no subjective symptoms, are best left alone. In older  men, who have neared the end of sexual life, we prefer to treat prostatic  calculosis by total prostatectomy, both when there is associated adenomatous  hypertrophy and when there is no hypertrophy but infection and fibrosis are  present. Prostatotomy, transurethral resection, and even the usual conservative  perineal or suprapubic prostatectomy often leave enough calculi or infected  prostate to cause persistence or recurrence of symptoms, as has been repeatedly  demonstrated by postoperative roentgenograms. Younger men with numerous stones  in their prostates should be treated by prostatectomy as a rule. Transurethral  resection is also frequently employed, but has the disadvantage that stones are  often left behind in the prostate.
<div class="fblike_button" style="margin: 10px 0;"><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2Fhealthandprostate.com%2Findex.php%2Fold-publications%2Fmedical-treatment-of-the-prostate-gland-part-10&amp;layout=standard&amp;show_faces=false&amp;width=450&amp;action=like&amp;colorscheme=light" scrolling="no" frameborder="0" allowTransparency="true" style="border:none; overflow:hidden; width:450px; height:25px"></iframe></div>
]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/index.php/old-publications/medical-treatment-of-the-prostate-gland-part-10/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
